Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of insulin detemir versus insulin glargine on glycaemic control and metabolism during exercise in Type 1 diabetes
2011-001209-28Phase 4Unknown
- Sponsor
- Buckinghamshire Healthcare NHS Trust
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin detemir and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Buckinghamshire Healthcare NHS Trust. Primary endpoint: Glucose excursion during exercise. Status: unknown.
02
Drugs
insulin detemirinsulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2011-001209-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001209-28.